Quick Answer
Verrica Pharmaceuticals Inc. reported Stockholders Equity of $24.74 million for fiscal year 2025.
Verrica Pharmaceuticals Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $24.74M | +350.9% |
| 2024 | -$9.86M | -149.9% |
| 2023 | $19.76M | -50.6% |
| 2022 | $40.03M | +22.8% |
| 2021 | $32.60M | -1.2% |
| 2020 | $32.99M | -49.3% |
| 2019 | $65.02M | -27.3% |
| 2018 | $89.43M | +1370.1% |
| 2017 | -$7.04M | -164.3% |
| 2016 | -$2.66M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$17.04M | +50.0% | +2.5% |
| June 30, 2025 | -$17.48M | -31.5% | +5.9% |
| March 31, 2025 | -$18.58M | -1331.8% | -88.4% |
| December 31, 2024 | -$9.86M | -149.9% | +71.0% |
| September 30, 2024 | -$34.05M | -180.5% | -156.0% |
| June 30, 2024 | -$13.30M | -124.0% | -982.0% |
| March 31, 2024 | $1.51M | -97.7% | -92.4% |
| December 31, 2023 | $19.76M | -50.6% | -53.3% |
- Verrica Pharmaceuticals Inc. showed an increase of +350.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2016–2025 period, Verrica Pharmaceuticals Inc.’s stockholders equity has grown by 1028.8% (from -$2.66 million to $24.74 million).
- The most recent figure is from Verrica Pharmaceuticals Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: